Craft

Aprogen

Total Funding

$16.7 M

Aprogen Summary

Company Summary

Overview
Aprogen is a biologics platform company focused on developing and manufacturing biosimilar products, protein drugs, and bispecific antibodies. It develops various recombinant antibody drugs aimed to minimize side-effects or immunogenicity for long-term treatment.
Type
Private
Status
Active
Founded
2000
Website
http://www.aprogen.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu